{"schema_version":"1","generated_at":"2026-11-04T08:46:57.982Z","data_as_of":null,"url":"https://www.findmykol.com/kol/robert-drapkin","json_url":"https://www.findmykol.com/kol/robert-drapkin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"robert-drapkin","name":"Robert Drapkin","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Clearwater","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1851399778","openalex":"A5078514750"},"summary":"Robert Drapkin is an Oncology physician. OpenAlex indexes 13 publications with 282 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":13,"cited_by_count":282,"h_index":6,"latest_activity_year":2022,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00132756","title":"Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer","phase":"PHASE1/PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Morton Plant Mease Health Care","source_url":"https://clinicaltrials.gov/study/NCT00132756","trial_url":"https://www.findmykol.com/trial/NCT00132756"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Acrotech Biopharma LLC","program_year":2022,"amount_usd":11.97,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851399778"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1851399778","source":"payments"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"OpenAlex author record","recent":[{"title":"Results of a Phase II Multicenter Trial of Pentostatin and Rituximab in Patients with Low-Grade B-Cell Non-Hodgkin's Lymphoma: An Effective and Minimally Toxic Regimen","year":2003,"journal":"Clinical Lymphoma","source_url":"https://doi.org/10.3816/clm.2003.n.026","status":"verified"},{"title":"Effect of Granisetron on Performance Status during High-Dose Interferon Therapy","year":1999,"journal":"Oncology","source_url":"https://doi.org/10.1159/000012065","status":"verified"},{"title":"Announcement","year":1999,"journal":"Oncology","source_url":"https://doi.org/10.1159/000012054","status":"verified"},{"title":"Book Reviews","year":1999,"journal":"Oncology","source_url":"https://doi.org/10.1159/000012053","status":"verified"},{"title":"Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content","year":1997,"journal":"Bone Marrow Transplantation","source_url":"https://doi.org/10.1038/sj.bmt.1700808","status":"verified"}],"source":"works"},"contact":{"address_1":"1003 BAY ESPLANADE","city":"Clearwater","state":"FL","zip":"337671019","phone":"727-461-1317","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1851399778","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":8}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2015-10-05","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}